Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Sales (2016 - 2025)

Historic Return on Sales for Ascendis Pharma A (ASND) over the last 12 years, with Q3 2025 value amounting to 0.25%.

  • Ascendis Pharma A's Return on Sales rose 14300.0% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 5600.0%. This contributed to the annual value of 0.91% for FY2024, which is 6800.0% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Return on Sales of 0.25% as of Q3 2025, which was up 14300.0% from 0.2% recorded in Q2 2025.
  • Over the past 5 years, Ascendis Pharma A's Return on Sales peaked at 0.12% during Q4 2024, and registered a low of 131.48% during Q2 2021.
  • In the last 5 years, Ascendis Pharma A's Return on Sales had a median value of 3.03% in 2024 and averaged 18.81%.
  • As far as peak fluctuations go, Ascendis Pharma A's Return on Sales tumbled by -653700bps in 2021, and later skyrocketed by 1182700bps in 2022.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Return on Sales stood at 1.23% in 2021, then plummeted by -598bps to 8.59% in 2022, then skyrocketed by 97bps to 0.25% in 2023, then soared by 53bps to 0.12% in 2024, then plummeted by -115bps to 0.25% in 2025.
  • Its Return on Sales stands at 0.25% for Q3 2025, versus 0.2% for Q2 2025 and 0.92% for Q1 2025.